Undergrads 2022 – part 2

Ali Nadi

Applying CRISPR/Cas9 and Fluorescent Tools to Dissect the Role of Tuberin in Cell Cycle Regulation 

How cells regulate their growth and division involves a tightly controlled integration of many mechanisms. In cells, Tuberin (gene – TSC2) is a protein in the Tuberous Sclerosis Complex (TSC) which modulates cellular growth, size, and proliferation. Mutations in the proteins forming the TSC can cause Tuberous Sclerosis Complex, an autosomal dominant disorder characterized by multisystem pathologies, and is often associated with benign hamartomas in the brain, kidney, lungs, and skin. The focus of my research is to clarify the role of Tuberin in the regulation of cell size and proliferation at the G2/M cell cycle checkpoint. During late G2, Tuberin retains Cyclin B1 (gene – CCNB1), a mitotic cyclin, in the cytoplasm thereby prolonging mitotic onset. We constructed six TSC2 mutants that harbour clinically relevant mutations which are known to destabilize the TSC. Interestingly, these mutations fall within the Tuberin Cyclin B1 binding domain. By over-expressing these Tuberin mutants in Tuberin null cells, an increased mitotic index is observed indicating a dysregulation of the G2/M transition. The resultant phenotypes are analyzed by flow cytometry, co-immunoprecipitation, and immunofluorescence. To aid in the temporal study of the cell cycle, we aim to validate successful CRISPR/Cas9-mediated knock-in of a near infrared (iRFP720) tag within the TSC2 gene of HEK293 cells, creating an endogenously expressed fluorescent Tuberin-RFP fusion protein. This new cell line will be a powerful tool to dissect the roles of Tuberin in regulating cellular growth and division and can provide a deep understanding of proliferative diseases like TSC and cancers. 

“When I first applied to be part of the Porter Lab back in the Spring of 2019, I knew that I was joining a well-recognized and large research lab on campus which has continuously been on the forefront of scientific discovery. However, I did not foresee the new family I would make during my time here. Over the past few years, I have grown from being a student volunteer that started off by filling ethanol bottles and pipette tip boxes to working on a project that uses CRISPR technology to create a modified HEK-293 cell line! My progress as a young scientist has been a direct result of the mentorship and teaching opportunities in the Porter lab ecosystem. It took no time for me to get my hands dirty with experiments at the start, and while the COVID-19 pandemic had put a slight pause on my progress, the lab still provided a means of learning new skills and leadership opportunities through the Peer Mentor Network! I have made many friendships during my time here, and while some of these friends are also starting new chapters in their careers and lives, our relationship will prove to withstand the test of time.  As I look forward to a life in medicine, these past few years have created a special place in my heart for biomedical research and it will certainly be a pillar of my future career. I am beyond grateful for the constant support that Dr. Lisa Porter and Dr. Elizabeth Fidalgo da Silva have given me this past year while also pushing me to do expand my scholarly boundaries. While embarking on my thesis this year, I have learned so many skills from troubleshooting experiments (shoutout to Adam Pillon for literally always being there to help) to communicate my work to both a general and scientific audience. As this chapter in my life nears an end, I will forever cherish the friendships and skillsets I have developed and will always have a special place in my heart for my fellow Porter lab rats. #porterlab #lifechanging #mentorship #futureinscience” 

Almas Khan
Spy1 Exacerbates the Long-Term Effects of Parity on the Mammary Gland
 
Age is a significant variable in cancer development, and approximately 1/3 of breast cancer cases occur in patients older than 70. Another emerging risk factor is parity, or childbearing, which may be linked to cellular changes that affect a woman’s risk of developing breast cancer over the course of her lifetime. These changes are thought to result from the mammary gland not reverting to normal
after lactation and involution – a developmental remodeling process where the milk secreting cells are cleared and replaced with adipocytes after weaning. Aberrant expression of the cyclin-like protein Spy1 has been shown to stimulate precocious development, resulting in disrupted morphology and oncogenesis within the mammary gland. Preliminary data suggests that the mammary glands of mice overexpressing Spy1 do not fully regress following lactation and involution, which may predispose them to breast cancer. We hypothesize that the overexpression of Spy1 exacerbates the long-term effects of parity on mammary gland morphology. To investigate this, we performed hematoxylin and eosin (H&E) staining as well as immunohistochemistry (IHC) on paraffin embedded sections, and whole mount staining of MMTV-Spy1 mice, a transgenic mouse model that overexpresses Spy1 within the mammary gland. We then compared the mammary gland morphology of parous MMTV-Spy1 mice to nulliparous MMTV-Spy1 mice, parous control FVB
mice, and nulliparous control FVB mice. This research begins to improve our understanding of Spy1’s role in regulating proliferation and apoptosis, contributes to our overall knowledge of breast cancer dynamics, and further solidifies Spy1 as an important target for treatment.
 
“When I first joined Porter lab, I was a volunteer with very little experience under the unprecedented circumstances of a pandemic. The amount of growth I have experienced as a scientist since then is astonishing, and I could not have imagined the full extent of it before I started as a thesis student. The environment and learning opportunities at Porter lab have been exceptional thanks to everyone’s commitment to our lab’s values, and I have met people and learned skills that will stay with me for the rest of my life. It still seems surreal to me to have been lucky enough to apply concepts, techniques, and an understanding of the scientific method from undergraduate courses to a real project with Implications on the field of mammary development and breast cancer research under the guidance of my mentors. I’m excited to pass the torch onto the next group of undergrads at the end of this journey, and excited to keep up with the lab’s future accomplishments.” 
 

Leave a Comment

Your email address will not be published. Required fields are marked *